jRCT2031210549进行中（未招募）不适用
Special use-results survey of ENAROY Tablets (long-term use)
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 1,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- No limit 至 No limit（—）
- 性别
- All
入选标准
- •(1) Patients using Enaroy for the first time for nephrogenic anemia
- •(2) Patients must provide informed consent before the start
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Special use-results survey of ENAROY Tablets(long-term use)Anemia associated with CKDJPRN-jRCT2031210549Patient Safety and Pharmacovigilance Dept.1,500
进行中（未招募）
不适用
Special Drug Use-results Survey of RIONA Tablets (Pregnant Patients with Iron Deficiency Anemia)Iron deficiency anaemiaJPRN-jRCT2031210322Dept. and Pharmacovigilance Patient Safety100
已完成
Unknown
Special Drug Use-Results Survey of Onoacttachyarrhythmia, atrial fibrillation/atrial flutter in patients with cardiac dysfunctionJPRN-jRCT1080222572ONO PHARMACEUTICAL CO., LTD.800
招募中
不适用
Survey of Brigatinib Used To Treat People With Non-Small Cell Lung Canceron-small cell lung cancerJPRN-jRCT2031210404Contact for Clinical Trial Information500
已完成
不适用
ORKEDIA Tablets Special Drug Use Results Survey -Survey on Long-Term Treatment in Patients with HemodialysisSecondary hyperparathyroidism (SHPT) on hemodialysisJPRN-UMIN000041834Kyowa Kirin Co., Ltd.2,542